glutathione kills triple negative cancer responsive nanomedicine leverages tumor redox imbalance for targeted theranostics | Discover Oncology Glutathione Depletion and Stalwart Anticancer
Glutathione Depletion and Stalwart Anticancer Activity of Metallotherapeutics Inducing Programmed Cell Death: Opening a New Window for Cancer Therapy ACS Omega Glutathione Dependent Pathways in Cancer Cells A review of biological targets and therapeutic approaches in the management of triple negative breast cancer ScienceDirect Role of Glutathione in Cancer: From Mechanisms to Therapies GSTP1 Is a Driver of Triple Negative Breast Cancer Cell Metabolism and Pathogenicity ScienceDirect Tumor targeted glutathione oxidation catalysis with ruthenium nanoreactors against hypoxic osteosarcoma Nature Communications
Pay in 4 interest-free payments of $7.32 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11





